SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001008848-12-000024
Filing Date
2012-04-26
Accepted
2012-04-26 17:17:27
Documents
7
Period of Report
2012-06-06
Effectiveness Date
2012-04-26

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT proxy-2012.htm DEF 14A 960800
2 PROXY CARD PAGE 1 acorda_card-page1.jpg GRAPHIC 169134
3 PROXY CARD PAGE 2 acorda_card-page2.jpg GRAPHIC 128099
4 NOTICE PAGE 1 acorda_notice-page1.jpg GRAPHIC 48414
5 NOTICE PAGE 2 acorda_notice-page2.jpg GRAPHIC 90910
6 NOTICE PAGE 3 acorda_notice-page3.jpg GRAPHIC 20902
7 NOTICE PAGE 4 acorda_notice-page4.jpg GRAPHIC 7194
  Complete submission text file 0001008848-12-000024.txt   1602886
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50513 | Film No.: 12784586
SIC: 2836 Biological Products, (No Diagnostic Substances)